Glutamate Biosensor Nanocomposite Electrode Direct Electron Transfer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting glutamate levels in vivo suffer from low sensitivity and poor spatiotemporal resolution, limiting the understanding and management of glutamate excitotoxicity in spinal cord injuries.
Innovation Solution
Development of an implantable biosensor using a nanocomposite electrode comprising platinum nanoparticles, multiwall carbon nanotubes, and a conductive polymer on a flexible substrate, enabling direct electron transfer for highly sensitive and specific amperometric glutamate detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional MEMS-based electrochemical biosensors are used for glutamate detection, then implantable in vivo measurement is enabled, but the sensors are rigid, expensive and time consuming to fabricate
Solution Approach 1:
The patent changes the fabrication parameters from conventional MEMS processes to direct-write printing methods, enabling flexible substrates and simplified manufacturing while maintaining detection sensitivity through optimized nanocomposite electrode formulations
Solution Approach 2:
The patent employs composite nanomaterials including carbon nanotubes, metal nanoparticles, and conductive polymers in the electrode formulation, achieving high detection sensitivity through enhanced electroactive surface area while using flexible polymer substrates that simplify fabrication
2Measurement precision
If existing non-invasive or invasive methods such as nuclear resonance imaging or microdialysis are used, then glutamate levels can be quantified, but sensitivity and spatiotemporal resolution are poor
Solution Approach 1:
The patent extracts the detection function from complex imaging or dialysis systems to a simple implantable electrochemical sensor that directly measures glutamate at the injury site, achieving high spatiotemporal resolution without complex external equipment
Solution Approach 2:
The patent replaces mechanical dialysis probes or imaging systems with an electrochemical detection system that uses electron transfer reactions to detect glutamate, enabling real-time measurement with superior temporal resolution
3Measurement precision
If conventional biosensors are used, then glutamate detection is possible, but sensitivity is low limiting understanding of glutamate excitotoxicity
Solution Approach 1:
The patent changes the physical parameters of the electrode by incorporating nanoscale materials that increase the electroactive surface area by orders of magnitude compared to conventional planar electrodes, enabling detection of low glutamate concentrations
Solution Approach 2:
The patent uses composite materials combining carbon nanotubes, metal nanoparticles, and conductive polymers to create electrodes with extremely high electroactive surface area that enhance sensitivity while maintaining biocompatibility for in vivo use
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biosensor achieves a sensitivity of 12.81±1.182 nA μM−1 mm−2 and a detection limit of 14 μM, with improved specificity and stability, allowing for precise monitoring of glutamate levels and potential therapeutic interventions in spinal cord injuries.
Implementation Method 1
The nanocomposite electrode comprises glutamate oxidase on the biosensor surface and is operable to detect direct electron transfer from L-glutamate by printing an amperometric response signal with an applied potential
Implementation Method 2
The nanocomposite electrode comprises glutamate oxidase on the biosensor surface
Implementation Method 3
detect direct electron transfer from L-glutamate
Data Source
AI summary
A direct electron transfer amperometric biosensor fabricated using direct write printing technology for in vivo electrochemical monitoring, such as monitoring of neurotransmitters and other biomarkers, e.g., in traumatic spinal cord injury. The biosensor is fabricated by immobilizing glutamate oxidase on nanocomposite electrodes made of platinum nanoparticles, multiwall carbon nanotubes and a conductive polymer on a flexible substrate.